Characteristics of DNMT3a mutation in acute myeloid leukemia and its prognostic implication

to related objects

Location: Deutsche Nationalbibliothek Frankfurt am Main

Extent: 1 Online-Ressource.

Language: Englisch

Bibliographic citation: Characteristics of DNMT3a mutation in acute myeloid leukemia and its prognostic implication ; volume:25 ; number:1 ; day:2 ; month:9 ; year:2024 ; pages:1-13 ; date:12.2024
The Egyptian journal of medical human genetics ; 25, Heft 1 (2.9.2024), 1-13, 12.2024

Creator: Khattab, Ahmed Mahmoud Taha
Ghaffar, Afaf Abdel Aziz Abdel
El-Sewefy, Dalia Ahmed
ElSakhawy, Yasmin Nabil
Salem, Ramy Mahmoud
Omar, Heba Samy Agamy

Contributor: SpringerLink (Online service)

DOI: 10.1186/s43042-024-00570-x

URN: urn:nbn:de:101:1-2411180021427.271139268941

Rights: Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.

Last update: 15.08.2025, 7:24 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Show original at data provider

Associated

Khattab, Ahmed Mahmoud Taha
Ghaffar, Afaf Abdel Aziz Abdel
El-Sewefy, Dalia Ahmed
ElSakhawy, Yasmin Nabil
Salem, Ramy Mahmoud
Omar, Heba Samy Agamy
SpringerLink (Online service)

Other Objects (12)

Quantitative detection of DNMT3A R882H mutation in acute myeloid leukemia

DNMT3A mutations in chronic myeloid leukemia

DNMT3A R882H mutation drives daunorubicin resistance in acute myeloid leukemia via regulating NRF2/NQO1 pathway

DNMT3A mutation promotes leukemia development through NAM-NAD metabolic reprogramming

Multi-omics analysis of DNMT3A- and NPM1-mutated acute myeloid leukemia

The methyltransferase domain of DNMT1 is an essential domain in acute myeloid leukemia independent of DNMT3A mutation

DNMT3A mutations and clinical features in Chinese patients with acute myeloid leukemia

Landscape of biallelic DNMT3A mutant myeloid neoplasms

DNMT3A mutations mediate the epigenetic reactivation of the leukemogenic factor MEIS1 in acute myeloid leukemia

Clinical features of De Novo acute myeloid leukemia with concurrent DNMT3A, FLT3 and NPM1 mutations

BCL2 overexpression: clinical implication and biological insights in acute myeloid leukemia

Recurrent SETD2 mutation in NPM1-mutated acute myeloid leukemia

Quantitative detection of DNMT3A R882H mutation in acute myeloid leukemia

DNMT3A mutations in chronic myeloid leukemia

DNMT3A R882H mutation drives daunorubicin resistance in acute myeloid leukemia via regulating NRF2/NQO1 pathway

DNMT3A mutation promotes leukemia development through NAM-NAD metabolic reprogramming

Multi-omics analysis of DNMT3A- and NPM1-mutated acute myeloid leukemia

The methyltransferase domain of DNMT1 is an essential domain in acute myeloid leukemia independent of DNMT3A mutation

DNMT3A mutations and clinical features in Chinese patients with acute myeloid leukemia

Landscape of biallelic DNMT3A mutant myeloid neoplasms

DNMT3A mutations mediate the epigenetic reactivation of the leukemogenic factor MEIS1 in acute myeloid leukemia

Clinical features of De Novo acute myeloid leukemia with concurrent DNMT3A, FLT3 and NPM1 mutations

BCL2 overexpression: clinical implication and biological insights in acute myeloid leukemia

Recurrent SETD2 mutation in NPM1-mutated acute myeloid leukemia

Quantitative detection of DNMT3A R882H mutation in acute myeloid leukemia

DNMT3A mutations in chronic myeloid leukemia

DNMT3A R882H mutation drives daunorubicin resistance in acute myeloid leukemia via regulating NRF2/NQO1 pathway

DNMT3A mutation promotes leukemia development through NAM-NAD metabolic reprogramming

Multi-omics analysis of DNMT3A- and NPM1-mutated acute myeloid leukemia

The methyltransferase domain of DNMT1 is an essential domain in acute myeloid leukemia independent of DNMT3A mutation

DNMT3A mutations and clinical features in Chinese patients with acute myeloid leukemia

Landscape of biallelic DNMT3A mutant myeloid neoplasms

DNMT3A mutations mediate the epigenetic reactivation of the leukemogenic factor MEIS1 in acute myeloid leukemia

Clinical features of De Novo acute myeloid leukemia with concurrent DNMT3A, FLT3 and NPM1 mutations

BCL2 overexpression: clinical implication and biological insights in acute myeloid leukemia

Recurrent SETD2 mutation in NPM1-mutated acute myeloid leukemia

Cultural heritage institutions wishing to register will find more information here.

Fields marked * need to be filled in.

Username*

Please enter your username

Email*

Please enter your email address

Please do not fill this field

First name

Last name

Password*

Please enter your password

Confirm password*

Please enter the same password

I have read the terms of use and the privacy policy for the collection of personal data and accept them. *

This field is required.

I would like to subscribe to the newsletter of the Deutsche Digitale Bibliothek. See newsletter subscription info.

Account created

Your "My DDB" account has been successfully created. Before you can log in to your account, you must click the confirmation link in the message we just sent to the email address you provided.

Characteristics of DNMT3a mutation in acute myeloid leukemia and its prognostic implication

Object Details

References and Relationships

Contributors, Places and Time

Further information

Data provider

Associated

Other Objects (12)

Quantitative detection of DNMT3A R882H mutation in acute myeloid leukemia

DNMT3A mutations in chronic myeloid leukemia

DNMT3A R882H mutation drives daunorubicin resistance in acute myeloid leukemia via regulating NRF2/NQO1 pathway

DNMT3A mutation promotes leukemia development through NAM-NAD metabolic reprogramming

Multi-omics analysis of DNMT3A- and NPM1-mutated acute myeloid leukemia

The methyltransferase domain of DNMT1 is an essential domain in acute myeloid leukemia independent of DNMT3A mutation

DNMT3A mutations and clinical features in Chinese patients with acute myeloid leukemia

Landscape of biallelic DNMT3A mutant myeloid neoplasms

DNMT3A mutations mediate the epigenetic reactivation of the leukemogenic factor MEIS1 in acute myeloid leukemia

Clinical features of De Novo acute myeloid leukemia with concurrent DNMT3A, FLT3 and NPM1 mutations

BCL2 overexpression: clinical implication and biological insights in acute myeloid leukemia

Recurrent SETD2 mutation in NPM1-mutated acute myeloid leukemia

Quantitative detection of DNMT3A R882H mutation in acute myeloid leukemia

DNMT3A mutations in chronic myeloid leukemia

DNMT3A R882H mutation drives daunorubicin resistance in acute myeloid leukemia via regulating NRF2/NQO1 pathway

DNMT3A mutation promotes leukemia development through NAM-NAD metabolic reprogramming

Multi-omics analysis of DNMT3A- and NPM1-mutated acute myeloid leukemia

The methyltransferase domain of DNMT1 is an essential domain in acute myeloid leukemia independent of DNMT3A mutation

DNMT3A mutations and clinical features in Chinese patients with acute myeloid leukemia

Landscape of biallelic DNMT3A mutant myeloid neoplasms

DNMT3A mutations mediate the epigenetic reactivation of the leukemogenic factor MEIS1 in acute myeloid leukemia

Clinical features of De Novo acute myeloid leukemia with concurrent DNMT3A, FLT3 and NPM1 mutations

BCL2 overexpression: clinical implication and biological insights in acute myeloid leukemia

Recurrent SETD2 mutation in NPM1-mutated acute myeloid leukemia

Quantitative detection of DNMT3A R882H mutation in acute myeloid leukemia

DNMT3A mutations in chronic myeloid leukemia

DNMT3A R882H mutation drives daunorubicin resistance in acute myeloid leukemia via regulating NRF2/NQO1 pathway

DNMT3A mutation promotes leukemia development through NAM-NAD metabolic reprogramming

Multi-omics analysis of DNMT3A- and NPM1-mutated acute myeloid leukemia

The methyltransferase domain of DNMT1 is an essential domain in acute myeloid leukemia independent of DNMT3A mutation

DNMT3A mutations and clinical features in Chinese patients with acute myeloid leukemia

Landscape of biallelic DNMT3A mutant myeloid neoplasms

DNMT3A mutations mediate the epigenetic reactivation of the leukemogenic factor MEIS1 in acute myeloid leukemia

Clinical features of De Novo acute myeloid leukemia with concurrent DNMT3A, FLT3 and NPM1 mutations

BCL2 overexpression: clinical implication and biological insights in acute myeloid leukemia

Recurrent SETD2 mutation in NPM1-mutated acute myeloid leukemia

Related objects

Reset password